https://orcid.org/0000-0002-6871-3213
References
- Watson OJ , Barnsley G , Toor J , Hogan AB , Winskill P , Ghani AC . Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect. Dis. 22(9), 1293–1302 (2022).
- Gupta M , Wahi A , Sharma P et al. Recent advances in cancer vaccines: challenges, achievements, and futuristic prospects. Vaccines 10(12), 2011 (2022).
- Benmerzoug S , Bounab B , Rose S et al. Sterile lung inflammation induced by silica exacerbates Mycobacterium tuberculosis infection via STING-dependent type 2 immunity. Cell Rep. 27(9), 2649–2664.e2645 (2019).
- He Z , Li C , Zhang X et al. The effects of gold nanoparticles on the human blood functions. Artif. Cells Nanomed. Biotechnol. 46(sup2), 720–726 (2018).
- Metselaar JM , Lammers T . Challenges in nanomedicine clinical translation. Drug Deliv. Transl. Res. 10(3), 721–725 (2020).
- Ozer I , Kelly G , Gu R et al. Polyethylene glycol-Like brush polymer conjugate of a protein drug does not induce an antipolymer immune response and has enhanced pharmacokinetics than its polyethylene glycol counterpart. Adv. Sci. 9(11), e2103672 (2022).
- Moghimi SM . Allergic reactions and anaphylaxis to LNP-based COVID-19 vaccines. Mol. Ther. 29(3), 898–900 (2021).
- Kozma GT , Mészáros T , Berényi P et al. Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: evidence for immunogenicity of PEG. Vaccine 41(31), 4561–4570 (2023).
- Ozer I , Pitoc GA , Layzer JM et al. PEG-Like brush polymer conjugate of RNA aptamer that shows reversible anticoagulant activity and minimal immune response. Adv. Mater. 34(10), 2107852 (2022).
- Ediriweera GR , Chang Y , Wang Q et al. Stimuli-responsive sulfoxide polymer–protein conjugates with improved pharmacokinetics and tumor delivery. Chem. Mater. 35(17), 7252–7265 (2023).
- Tian Y , Gao Z , Wang N et al. Engineering poly(ethylene glycol) nanoparticles for accelerated blood clearance inhibition and targeted drug delivery. J. Am. Chem. Soc. 144(40), 18419–18428 (2022).
- Zhou L-Y , Zhu Y-H , Wang X-Y et al. Novel zwitterionic vectors: multi-functional delivery systems for therapeutic genes and drugs. Comput. Struct. Biotechnol. J. 18, 1980–1999 (2020).
- Hu C-MJ , Zhang L , Aryal S , Cheung C , Fang RH , Zhang L . Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc. Nat. Acad. Sci. USA 108(27), 10980–10985 (2011).
- Kim MW , Lee G , Niidome T , Komohara Y , Lee R , Park YI . Platelet-like gold nanostars for cancer therapy: the ability to treat cancer and evade immune reactions. Front. Bioeng. Biotechnol. 8, 133 (2020).
- Tan Q , He L , Meng X et al. Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19. J. Nanobiotechnol. 19(1), 173 (2021).
- Huang X , Guo H , Wang L , Zhang Z , Zhang W . Biomimetic cell membrane-coated nanocarriers for targeted siRNA delivery in cancer therapy. Drug Discov. Today 28(4), 103514 (2023).
- Ghorai SM , Deep A , Magoo D , Gupta C , Gupta N . Cell-penetrating and targeted peptides delivery systems as potential pharmaceutical carriers for enhanced delivery across the blood–brain barrier (BBB). Pharmaceutics 15(7), 1999 (2023).
- Chen Z , Chen X , Huang J , Wang J , Wang Z . Harnessing protein corona for biomimetic nanomedicine design. Biomimetics 7(3), 126 (2022).
- Simon J , Müller LK , Kokkinopoulou M et al. Exploiting the biomolecular corona: pre-coating of nanoparticles enables controlled cellular interactions. Nanoscale 10(22), 10731–10739 (2018).
- Zhang Z , Guan J , Jiang Z et al. Brain-targeted drug delivery by manipulating protein corona functions. Nat. Commun. 10(1), 3561 (2019).